Apr 26, 2016 at 08:27 | Source: CNBC-TV18
CNBC-TV18's analysts gives stocks to keep on your radar for trade today - stocks expected to be under pressure today are ABB India, IPCA Labs, State Bank of Travancore, Sun Pharma, ITC, Godfrey Phillips and VST Industries while the stocks expected to gain are Indiabulls Housing, Bharti Airtel, Shilcar Tech, Novartis India and Excel Crop Care.
Apr 22, 2016 at 11:21 | Source: Reuters
Although the world's biggest prescription drugmaker's first-quarter core net income fell 13 percent to USD 2.79 billion, it beat the USD 2.76 billion average of estimates from analysts polled by Reuters and lifted the company's shares.
Apr 20, 2016 at 11:44 | Source: Moneycontrol.com
Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 19, 2016, approved appointment of Ms. Sandra Martryes as Additional Director on the Board of Directors of the Company w.e.f. April 19, 2016. She will hold office up to the date of the next Annual General Meeting (AGM) of the Company.
Apr 11, 2016 at 17:24 | Source: PTI
"We are confident that this partnership for Loftair will enable us to further consolidate and strengthen our market leadership within the Indian COPD, Anti-Asthma, Inhalation therapy segments," Lupin India Region Formulations Group President Shakti Chakraborty said.
Apr 11, 2016 at 15:47 | Source: Moneycontrol.com
Lupin and Novartis Healthcare have entered into a co-marketing agreement to promote Novartiss Indacaterol / Glycopyrronium 110mcg/50mcg inhaler, a treatment for chronic obstructive pulmonary disease (COPD) under the brand name of Loftair.
Mar 30, 2016 at 09:42 | Source: Moneycontrol.com
"A wholly-owned subsidiary of Sun Pharma will acquire portfolio consisting of 14 established prescription brands from Novartis for a cash consideration of USD 293 million," says the company.
Mar 30, 2016 at 08:44 | Source: PTI
According to the agreements signed by the parties, a wholly-owned subsidiary of Sun Pharma will acquire the portfolio consisting of 14 established prescription brands from Novartis for a cash consideration of USD 293 million, Sun Pharma said in a statement.
Mar 30, 2016 at 08:40 | Source: Moneycontrol.com
Sun Pharma today announced the acquisition of 14 established prescription brands from Novartis AG and Novartis Pharma AG in Japan.
Mar 21, 2016 at 19:49 | Source: Moneycontrol.com
The Sharepro website claims Larsen & Toubro Finance Holdings, Bajaj Hindusthan, Hexaware, Ultratech Cement, Dena Bank, Bank of India, Zee, Godfrey Phillips, Mahindra Lifespaces, Abbot India, Clariant, Novartis, BASF, Balmer & Lawrie and Bombay Dyeing among its main clients